Literature DB >> 6288409

Potentiation of phenobarbital-induced anticonvulsant activity by pipecolic acid.

K Takahama, T Miyata, Y Okano, M Kataoka, T Hitoshi, Y Kasé.   

Abstract

Pipecolic acid (PA) is an intermediate of lysine metabolism in the mammalian brain. Recent findings suggest a functional connection of PA as neuromodulator in GABAergic transmission. Since many drugs are postulated to produce their effects by interaction with the central GABA system, the influence of PA on the anticonvulsant activity of phenobarbital was examined. Pretreatment of mice with 50 mg . kg-1 of PA potentiated the suppressing effects of the barbiturate on electrically and chemically induced convulsions. However, there was no potentiation of the behavioral effects and hypothermia induced by phenobarbital. PA itself had no or only little effect on the convulsions, motor function and rectal temperature when given in i.p. doses up to 500 mg . kg-1. Intraventricular administration of 500 microgram of PA also did not suppress either type of convulsion, although it produced ptosis, hypotonia, sedation and hypothermia. The results are discussed in relation to GABA system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288409     DOI: 10.1016/0014-2999(82)90452-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Pipecolic Acid, a Putative Mediator of the Encephalopathy of Cerebral Malaria and the Experimental Model of Cerebral Malaria.

Authors:  Tarun Keswani; Aisha Obeidallah; Edward Nieves; Simone Sidoli; Melissa Fazzari; Terrie Taylor; Karl Seydel; Johanna P Daily
Journal:  J Infect Dis       Date:  2022-02-15       Impact factor: 5.226

2.  High-affinity binding of proline to mouse brain synaptic membranes.

Authors:  J G Ortiz; A E Negrón; M S Bruno
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

3.  L-lysine is a barbiturate-like anticonvulsant and modulator of the benzodiazepine receptor.

Authors:  Y F Chang; X M Gao
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.